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Ectopic bone formation is a unique biologic entity—distinct from other areas of skeletal biology. Animal research
models of ectopic bone formation most often employ rodent models and have unique advantages over ortho-
topic (bone) environments, including a relative lack of bone cytokine stimulation and cell-to-cell interaction with
endogenous (host) bone-forming cells. This allows for relatively controlled in vivo experimental bone formation.
A wide variety of ectopic locations have been used for experimentation, including subcutaneous, intramuscular,
and kidney capsule transplantation. The method, benefits and detractions of each method are summarized in the
following review. Briefly, subcutaneous implantation is the simplest method. However, the most pertinent
concern is the relative paucity of bone formation in comparison to other models. Intramuscular implantation is
also widely used and relatively simple, however intramuscular implants are exposed to skeletal muscle satellite
progenitor cells. Thus, distinguishing host from donor osteogenesis becomes challenging without cell-tracking
studies. The kidney capsule (perirenal or renal capsule) method is less widely used and more technically
challenging. It allows for supraphysiologic blood and nutrient resource, promoting robust bone growth. In
summary, ectopic bone models are extremely useful in the evaluation of bone-forming stem cells, new os-
teoinductive biomaterials, and growth factors; an appropriate choice of model, however, will greatly increase
experimental success.
What Is Ectopic Bone Formation?
Ectopic bone, from the Greek word ektopos or ‘‘awayfrom a place,’’ refers to the ossification of tissues outside
their usual origins. Ectopic bone formation is most often ex-
perimentally induced, but does also have clinical relevance. For
example, ectopic bone has long been described as a congenital
or inherited malformation [1–4], or a complication of various
conditions such as paraplegia [5,6], posthip arthroplasty [7,8],
postburn, or traumatic injury [9–11]. Such pathologic forma-
tion of endochondral bone in soft tissues such as muscle, sub-
cutaneous tissue, and fibrous tissue adjacent to joints is called
heterotopic ossification (HO). Up to 10% of patients who have
invasive surgery will develop this debilitating complication,
which is thought to be caused by local inflammation followed
by recruitment of skeletal progenitor cells [12,13]. Though less
frequently observed, hereditary forms of ectopic bone forma-
tion also exist. One such disease entity is called fibrodysplasia
ossificans progressiva resulting from a mutation in the ACVR1
gene that causes upregulation of BMP1 [14]. Experimental in-
duction of bone tissue has been long-standing, first in muscle
pouch and subcutaneous models [15,16], and more recently in
the kidney capsule model. Each of these experimental entities
offers distinct advantages and drawbacks that will be dis-
cussed below.
Ectopic Versus Orthotopic Bone Formation
The distinction between ectopic and orthotopic bone for-
mation is an important one. Orthotopic bone formation is
derived from the greek word orthos meaning ‘‘straight, right’’
and refers to studies in which bone is formed in its correct
anatomical location. Such studies can either be nonsurgical
(eg, the injection of materials into the long bone periosteum)
or surgical (eg, a calvarial defect in which material is grafted
in the defect site). In these instances, the distinct biochemical
and mechanical environment of an orthotopic bone model
should not be overlooked. Bone injury has long been un-
derstood to elicit a cascade of signaling pathway activation,
including fibroblast growth factor [17], transforming growth
factor-beta (TGF-b) [18], Hedgehog [19], and Wingless Pro-
tein (Wnt) signaling [20] among others. This upregulation of
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pro-osteogenic signaling cascades has been shown to be
critical for successful MSC-mediated osseous repair of bone
injury [21]. The bone morphogenetic protein (BMP) signal-
ing pathway, for example, is acutely upregulated in a
mouse calvarial defect model. This upregulation enables
adipose-derived stem cells to successfully ossify a critical-
sized defect [21].
The mechanical forces exerted on a graft site should be
considered as well. MSC transplantation into a long bone
defect is subject to significant stress/strain forces with
weight-bearing and locomotion [22]. In contrast, ectopic
models are largely void of mechanical force (perhaps slight
compression of the implant depending on its size can be
observed, especially in the kidney capsule model). Bio-
mechanical forces are well-studied, involving a cascade of
signaling events leading to bone formation, or ‘‘mechano-
transduction’’ [22–25]. It is important to realize that ectopic
bone models allow for near-complete removal of this po-
tential extraneous experimental variable. Thus, ectopic bone
formation models reduce the number of variables involved
in bone formation, eliminating (or reducing) the effects of
bone stimulating cytokines, bone forming cells, endogenous
stem cells, and potentially bone-stimulating mechan-
otransduction. Each of the commonly used models discussed
below has significant advantages and drawbacks.
Models of Ectopic Bone Formation
Subcutaneous implantation
Subcutaneous implantation is the most simplistic of all
experimental models of ectopic bone formation. Surgically, it
is the easiest of all models and a novice can perform this
procedure with success after learning basic suturing tech-
nique. Nearly any mammalian animal model can be chosen,
ranging from mouse and rat to rabbit, dog, and pig among
numerous others (see Table 1 for a review). Rodent models
are preferable and most widely used due to their low cost,
lax skin (which accommodates large-volume implants), and
availability of immunodeficient rodents for xenograft-based
experiments. Generally, incisions should be made on the
dorsum of the rodent so as to prevent the animals from re-
moving their own sutures. Alternatively, intradermal stitches
can be placed which avoids the possible need to dress the
wound. Classically, bone marrow derived mesenchymal
stem cells (BMSCs) are the most commonly studied cell type
(Table 1). The availability of immunodeficient rats and mice
makes possible and practical the transplantation of human-
derived cells for increased clinical relevance. Cells may be
transplanted immediately after derivation, after culture ex-
pansion, or after predifferentiation [26]. In such cases, pre-
differentiation may ensure adequate in vivo bone formation.
However, culture time and conditions may change the
overall composition of a cell population [27,28]. Further,
predifferentiation is less ideal for clinical translation as the
barrier for regulatory approval is higher if cells are taken
ex vivo before implantation. Mesenchymal cells have been
shown to have the ability to form bone when placed in an
osteogenic environment; however, subcutaneous implanta-
tion often requires cytokine supplementation or molecular
modifications [29,30]. Cell delivery methods are widely
variable, from stiff poly lactic glycolic acid, to composite gels
and other matrices. As an alternative to material scaffolds,
culture-expanded cell sheets can be rolled and implanted
without a carrier, showing new bone formation [31]. In ad-
dition, various growth factors and other stimuli have been
added such as BMP2 and vascular endothelial growth factor
to name a few (see again Table 1).
One of the more important considerations for subcutane-
ous bone models is a technical one. The physical identifica-
tion of the implant can be challenging, especially as newly-
formed bone can be similar in color to the surrounding
dermal tissues. Moreover, the lax skin of rodents allows for
potentially significant migration of an implant, a difficulty
that can be compounded by small implant sizes. The authors
suggest the use of colored scaffolds or the labeling of cells/
implants with a dye before implantation to facilitate identi-
fication upon removal. This becomes increasingly important
with longer-term studies with months separating implanta-
tion and harvest.
Another consideration for subcutaneous bone formation is
the theoretical lack of naturally bone-forming stem cells
within the intradermal environment. This is in direct contrast
to intramuscular bone formation (see below) in which stri-
ated muscle satellite progenitor cells are readily able to form
bone, given an appropriate osteogenic stimulus. This lack of
endogenous bone-forming cells may be a benefit or a dis-
advantage depending on the experimental design. For ex-
ample, it may be a benefit if an exogenous stem cell is
implanted, ensuring that in theory the predominant, newly-
formed bone is from exogenous origin. On the other hand, it
may be a detraction if the study is designed to expressly test
a biomaterial scaffold, in which case an endogenous bone-
forming stromal cell may be needed to ensure adequate bone
formation. A similar caveat should also be considered in
subcutaneous models: skin injury has been shown to result in
the honing of circulating progenitor cells to the defect site
[32], and one cannot definitively exclude these progenitor
cell types from participating in bone formation.
Finally, subcutaneous models may show inferior bone-
forming capacity in comparison to other experimental
models of ectopic bone formation. In general, relatively
greater ectopic bone formation is observed within the intra-
muscular compartment compared with intradermal com-
partment [33]. For example, in one study performed on dogs
and pigs, bone formation could be histologically observed
after 45 days after intramuscular transplantation in contrast
to 60 days after subcutaneous implantation [34]. However,
exceptions to this general observation do exist, where, for
example, a particular nano-crystalline hydroxyapatite scaf-
fold produced significantly more subcutaneous rather than
intramuscular bone in minipigs [35]. In general, the reduced
ectopic bone formation in subcutaneous models may be due
to reduced vascularization and blood flow—which is espe-
cially striking in comparison to the infrarenal capsule model
as discussed below. Therefore, a lack of robust subcutaneous
bone formation and the need for extended in vivo ‘‘incuba-
tion’’ times may limit the utility of subcutaneous models.
Muscle pouch implantation
Muscle Pouch (or intramuscular) implantation has a rich
history in bone formation. In fact, BMPs were first studied
for their ability to induce bone formation in a muscle pouch
model [36]. Like subcutaneous ectopic bone formation,





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































intramuscular bone formation may also be used in nearly
any animal model (see Table 2). Although the mainstay re-
mains rodent models, intramuscular implantation is read-
ily translatable to larger animals (dog, pig, goat, and
sheep). Intramuscular implantation has also been used in the
human patient to successfully generate bone. For example, in
2004 Warnke et al. reported the intramuscular growth of a
replacement human mandible using autologous bone mar-
row and BMP7 [37]. As another example, Heliotis et al.
determined that even without added stem cells, BMP7 with
hydroxyapatite can lead to replacement mandible ossifica-
tion [38].
In small animal models, the hind limb is preferentially
used. Generally, the authors suggest implantation in the
thigh complex that affords space for a large-volume implant.
In the thigh muscles of a mouse, for example, a maximum
volume of up to *150 mL can be implanted. By contrast, the
lower leg can be used for smaller volume implants. Benefits
of using the lower leg are a readily palpable implant that can
be monitored for growth or imaged by surface ultrasound if
desired. Intramuscular implantation in a large animal is most
often in the dorsal musculature, including paraspinal mus-
cles or trapezius.
In recent years, BMP2 and other BMPs have been widely
studied in intramuscular ectopic bone models [39]. BMPs are
known to stimulate the osteogenic differentiation of native
skeletal muscle satellite cells. This reinforces an important
distinction between the intramuscular implantation model
and other ectopic bone models: the presence of a native
skeletal progenitor cells. If another osteoprogenitor cell
source is experimentally implanted in a muscle pouch envi-
ronment, it becomes critical to identify the cells on later
histological analysis. This can be achieved by transfection
with a reporter system, by gender mismatch of host and
donor, or by xenografting and detection of species-specific
antigens among other techniques. These techniques will al-
low for definitive identification of hosts from donor-derived
bone. This extra step in analysis is vital for valid interpre-
tation of intramuscular bone formation and could be a con-
sideration to opt for another ectopic bone formation assay.
Another critical distinction to make for intramuscular
implantation experiments is that of the pro-osteogenic cyto-
kine elaboration from sites of muscle injury. BMP signaling
has been shown to be naturally upregulated postmuscle in-
jury via Smad activation [40,41]. Normally this is important
for the regulation of proliferation and myogenic differentia-
tion of skeletal muscle satellite cells and their descendants.
However, this heightened BMP signaling postmuscle injury
theoretically represents a potentially confounding factor in
intramuscular ectopic bone models. Like BMP signaling,
other signaling pathways known to be important in osteo-
genesis are also upregulated by muscular injury. These in-
clude TGF-b1 and insulin-like growth factor 1 to name a few
[42,43]. In light of these findings, it is important to utilize
blunt dissection rather than traumatic sheering of muscle
fibers when creating the potential space for implant inser-
tion. A relatively atraumatic muscle pocket creation will
theoretically minimize this natural upregulation of BMP and
other pro-osteogenic cytokines. On that note, similar cyto-
kines are upregulated after cutaneous injury (most promi-
nently TGF-b1), and may also play a confounding role in
subcutaneous ectopic bone models.
Kidney capsule implantation
The kidney capsule model is a less frequently used
method of ectopic bone formation, primarily owing to its
relative technical difficulty in comparison to subcutaneous
or intramuscular transplantation. Material is placed be-
tween the thin, fibrous capsule of the kidney and the un-
derlying renal parenchyma. This material can be inserted
either directly by injection with a small gauge needle, or
surgically by creating a small incision in the capsule and
gently inserting the material underneath the capsule. For
the insertion method, a space should be created using
blunt dissection (eg, using a melted Pasteur pipette). Un-
like in primates, the kidney of rodents is an intraperitoneal
organ and so the peritoneum must be incised before vi-
sualization of the kidney. The surgical insertion method is
more technically challenging than the injection method, so
prior practice is advisable. Most importantly, the capsule
should remain intact to ensure that the implant stays in
place and that proper vascularization will ensue. Material
should not be injected into the parenchyma of the organ.
Both the peritoneum and skin should be sutured after
implantation.
A list of recent citations using the kidney capsule model
for bone formation can be found in Table 3. The majority of
studies utilize mice (either wild-type or immunocompro-
mised), while a few use rats. BMSCs are the most commonly
studied cell type, while cells derived from the tooth are often
studied as well. A wide array of materials can be used for
implantation including gels, bone matrices, and biodegrad-
able sponges. A cell suspension or cell pellet can be injected
as well, without any scaffold or carrier. The majority of im-
plants are thereafter analyzed from 1 to 4 weeks post-
implantation, but studies even up to 10 months in length
have been described [44].
Significant features of the renal capsule model include: (1)
increased blood flow to the implant, (2) theoretical lack of
endogenous bone-forming stem cells, (3) size limitations of
the implant, and (4) compressive force on the implant. Each
will be considered in turn below. First, implants placed in the
subrenal capsular assay are exposed to significant blood flow
and likewise blood-borne nutrients. This has led in reports to
supraphysiologic bone growth in comparison to native bone
samples [45]. However, this can be considered a benefit ra-
ther than a detraction as engrafted cells are likely to survive
and proliferate once in place. Moreover, the highly vascular
environment may allow for the development of complex
tissue types such as tooth-like structures in the field of dental
research [46–48] and calvarial suture-like structures [45].
Secondly, the subrenal capsule microenvironment is theo-
retically free of bone-forming endogenous stem cells. While
trafficking of endogenous stem cells is theoretical, it is almost
certain that the engrafted cells are responsible for any ob-
served bone formation. Third, limitations on the size of im-
plant can be of concern, as larger volumes can inadvertently
tear the capsule. While mice are most often used, rats can be
substituted for larger implants (Table 3). Fourth and finally,
the capsular tissue overlying the engrafted cells may be fairly
taut, especially if large-volume implants are used. This can
relay a compressive force onto the implant itself, which may
predispose to cartilage over bone formation depending on
the cell type [49–51].


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Experimentally induced ectopic bone formation is a well-
studied, well-described entity with subcutaneous, intra-
muscular, and kidney capsule transplantation being the
most common models. Briefly, the most pertinent concern
for subcutaneous implantation is the potential lack of ro-
bust bone growth, potentially attributable to poor blood
flow. Intramuscular implantation exposes the implant to
satellite progenitor cells, which theoretically makes distin-
guishing host from donor osteogenesis difficult. The kidney
capsule method allows for supraphysiologic blood and
nutrient resource, allowing for robust bone growth despite
being a technically challenging assay. All 3 models are valid
experimental entities; however, their distinct differences
should be taken into account when either constructing or
analyzing an experiment. Analyses of such models are
crucial to understand the osteogenic differentiation of cells
independent from an osseous environment. Thus, as skel-
etal tissue engineering progresses and the use of osteogenic
progenitor cells becomes more commonplace, such models
will hopefully allow for optimization of bone formation.
Conversely, understanding the biology of ectopic bone
formation might also allow for improved treatments of
debilitations such as HO.
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